[ad_1] Rain Therapeutics RAIN has completed patient enrolment in its Phase 3 MANTRA trial of its lead asset, milademetan for well-differentiated / dedifferentiated (WD/DD) liposarcoma (LPS). The MANTRA study is…
[ad_1] According to Benzinga Pro, during Q2, Cullen/Frost Bankers CFR earned $119.11 million, a 20.19% increase from the preceding quarter. Cullen/Frost Bankers also posted a total of $409.30 million in…
[ad_1] Dun & Bradstreet Hldgs DNB reported its Q2 earnings results on Thursday, August 4, 2022 at 08:00 AM. Here’s what investors need to know about the announcement. Earnings…
[ad_1] U.S. stocks rose sharply on Wednesday, with Treasury yields climbing to two-week highs on Wednesday following better-than-expected economic data and strong projections from some major companies. All the three…
[ad_1] Robinhood Markets, Inc HOOD CEO Vlad Tenev says he loves the trading platform as a “standalone” company. What Happened: Tenev made his comments on a second-quarter earnings call on Wednesday. He was asked…